BDRL — Blonder Tongue Laboratories Income Statement
0.000.00%
Last trade - 00:00- $0.46m
- $5.06m
- $11.17m
Annual income statement for Blonder Tongue Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 16.4 | 15.8 | 18.1 | 13.2 | 11.2 |
| Cost of Revenue | |||||
| Gross Profit | 3.02 | 5.86 | 5.46 | 3.98 | 3.71 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 23.5 | 16.9 | 20.2 | 14.5 | 11.8 |
| Operating Profit | -7.11 | -1.19 | -2.13 | -1.26 | -0.682 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.46 | 0.099 | -2.92 | -2.1 | -1.24 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.47 | 0.084 | -2.92 | -2.12 | -1.25 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.47 | 0.084 | -2.92 | -2.12 | -1.25 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.47 | 0.084 | -2.92 | -2.12 | -1.25 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.755 | -0.069 | -0.22 | -0.151 | -0.086 |